Lippincott Journals Subscribers, use your username or email along with your password to log in.
Registered users can save articles, searches, and manage email alerts.
All registration fields are required.
Article/items published online ahead of print or online only
Latest Entry: Alvocidib in Combo With Cytarabine & Daunorubicin in Newly Diagnosed AML
6/23/2019 Zella 101 Evaluates Alvocidib in Combination With Cytarabine & Daunorubicin in Newly Diagnosed AML
FDA ACTIONS & UPDATES
The latest approvals, designations, and new indications from the U.S. Food and Drug Administration for oncology drugs.
Latest: Tinostamustine Granted Orphan Drug Designation for T-Cell Prolymphocytic Leukemia
MUSINGS OF A CANCER DOCTORBy George W. Sledge, Jr., MDObservations, ponderings, and views.
Latest Entry: Smoke Gets in Your Eyes
ONCOLOGISTS' GUIDE TO GENOMICSThe latest trends in genomics and molecular diagnostics for oncology.
Latest Entry: Real-World Insights Into Germline Genetic Testing for Prostate Cancer
VIEW FROM THE OTHER SIDE OF THE STETHOSCOPEBy Wendy S. Harpham, MD, FACPA unique perspective on oncology practices.
Latest Entry: Checking Out God's Hotel
3 QUESTIONS ON...Answers straight from the experts on the latest news and topics in oncology.
Latest Entry: The Role of the Hospital at Home Model in Oncology
August 25, 2016 - Volume 38 - 16
August 25, 2016
July 10, 2016 - Volume 38 - 13
February 10th, 2013 - Volume 35 - SABCS Meeting Reporter Special Edition Supplement
All the latest news,
plus a look back at
OT's comprehensive coverage on...
And for more topics in oncology, browse our full list of
Exclusive interviews and perspectives from our iPad archives
Most Recently Added: "How Health IT is Changing Oncology"—Andrew Zelenetz, MD, PhD, Chief of the Lymphoma Service and Vice Chair of Medical Informatics at Memorial Sloan Kettering Cancer Center, tells OT how oncologists there are training a computer to understand and compare big data sets...